Autologous regenerative skin cell therapy(University of Zurich)(Autologous regenerative skin cell therapy(University of Zurich))

概要

基本信息

药物类型

细胞疗法

别名

EHSG-KF

靶点-

作用方式-

作用机制-

治疗领域

其他疾病

在研适应症

烧伤

非在研适应症-

原研机构

University of Zurich

在研机构

University of Zurich

CUTISS AG初创企业

非在研机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

3

项与 Autologous regenerative skin cell therapy(University of Zurich) 相关的临床试验

NCT03394612

/ Active, not recruiting临床2期

A Phase II, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Full-Thickness Defects in Adults and Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)

This phase II trial aims to evaluate the efficacy and safety of EHSG-KF (synonym denovoSkin) in comparison to meshed STSG in adults and children with full-thickness Skin defects.

开始日期2018-02-14

申办/合作机构

CUTISS AG初创企业

[+4]

NCT03229564

/ Recruiting临床2期

A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)

This phase IIb trial aims to evaluate the efficacy and safety of EHSG-KF (synonym denovoSkin) in comparison to meshed STSG in children with partial deep dermal and full thickness burns.

开始日期2017-10-25

申办/合作机构

CUTISS AG初创企业

[+4]

NCT03227146

/ Active, not recruiting临床2期

A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents in Comparison to Autologous Split-thickness Skin Grafts (STSG)

This phase IIb trial aims to evaluate the efficacy and safety of EHSG-KF (synonym denovoSkin) in comparison to meshed STSG in adults and adolescents with partial deep dermal and full thickness burns.

开始日期2017-10-25

申办/合作机构

CUTISS AG初创企业

[+4]

100 项与 Autologous regenerative skin cell therapy(University of Zurich) 相关的临床结果

登录后查看更多信息

100 项与 Autologous regenerative skin cell therapy(University of Zurich) 相关的转化医学

登录后查看更多信息

100 项与 Autologous regenerative skin cell therapy(University of Zurich) 相关的专利（医药）

登录后查看更多信息

100 项与 Autologous regenerative skin cell therapy(University of Zurich) 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
烧伤	临床2期	意大利	CUTISS AG初创企业	2017-10-25
烧伤	临床2期	意大利	University of Zurich	2017-10-25
烧伤	临床2期	荷兰	University of Zurich	2017-10-25
烧伤	临床2期	荷兰	CUTISS AG初创企业	2017-10-25
烧伤	临床2期	瑞士	University of Zurich	2017-10-25
烧伤	临床2期	瑞士	CUTISS AG初创企业	2017-10-25